Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 138

1.

When to consider electroconvulsive therapy (ECT).

Kellner CH, Obbels J, Sienaert P.

Acta Psychiatr Scand. 2019 Nov 27. doi: 10.1111/acps.13134. [Epub ahead of print]

PMID:
31774547
2.

Melancholia as Predictor of Electroconvulsive Therapy Outcome in Later Life.

Veltman EM, de Boer A, Dols A, van Exel E, Stek ML, Sienaert P, Bouckaert F, van der Mast R, Rhebergen D.

J ECT. 2019 Dec;35(4):231-237. doi: 10.1097/YCT.0000000000000579.

PMID:
31764445
3.

The psychopharmacology of catatonia, neuroleptic malignant syndrome, akathisia, tardive dyskinesia, and dystonia.

Sienaert P, van Harten P, Rhebergen D.

Handb Clin Neurol. 2019;165:415-428. doi: 10.1016/B978-0-444-64012-3.00025-3.

PMID:
31727227
4.

Electric field causes volumetric changes in the human brain.

Argyelan M, Oltedal L, Deng ZD, Wade B, Bikson M, Joanlanne A, Sanghani S, Bartsch H, Cano M, Dale AM, Dannlowski U, Dols A, Enneking V, Espinoza R, Kessler U, Narr KL, Oedegaard KJ, Oudega ML, Redlich R, Stek ML, Takamiya A, Emsell L, Bouckaert F, Sienaert P, Pujol J, Tendolkar I, van Eijndhoven P, Petrides G, Malhotra AK, Abbott C.

Elife. 2019 Oct 23;8. pii: e49115. doi: 10.7554/eLife.49115.

5.

S100 calcium-binding protein B in older patients with depression treated with electroconvulsive therapy.

Carlier A, Boers K, Veerhuis R, Bouckaert F, Sienaert P, Eikelenboom P, Vandenbulcke M, Stek ML, van Exel E, Dols A, Rhebergen D.

Psychoneuroendocrinology. 2019 Dec;110:104414. doi: 10.1016/j.psyneuen.2019.104414. Epub 2019 Aug 24.

PMID:
31493698
6.

Hippocampal volume change following ECT is mediated by rs699947 in the promotor region of VEGF.

Van Den Bossche MJA, Emsell L, Dols A, Vansteelandt K, De Winter FL, Van den Stock J, Sienaert P, Stek ML, Bouckaert F, Vandenbulcke M.

Transl Psychiatry. 2019 Aug 20;9(1):191. doi: 10.1038/s41398-019-0530-6.

7.

Cortisol is not associated with pre-treatment medial temporal lobe volume or volume changes after electroconvulsive therapy in patients with late-life depression.

Laroy M, Weydts J, Vansteelandt K, Emsell L, Adamson C, Sienaert P, Dols A, Rhebergen D, Stek M, Vandenbulcke M, Bouckaert F.

Psychiatry Res Neuroimaging. 2019 Sep 30;291:26-33. doi: 10.1016/j.pscychresns.2019.07.006. Epub 2019 Jul 29.

PMID:
31421610
8.

Association between hippocampal volume change and change in memory following electroconvulsive therapy in late-life depression.

Laroy M, Bouckaert F, Vansteelandt K, Obbels J, Dols A, Emsell L, Stek M, Vandenbulcke M, Sienaert P.

Acta Psychiatr Scand. 2019 Nov;140(5):435-445. doi: 10.1111/acps.13086. Epub 2019 Sep 6.

PMID:
31411340
9.

Hepatic encephalopathy resulting in mania, a possible role of bilirubin and glutamate?

Mortier P, Tu H, Van Walleghem D, Wyckaert S, Sienaert P.

Bipolar Disord. 2019 Sep;21(6):565-567. doi: 10.1111/bdi.12818. Epub 2019 Aug 21. No abstract available.

PMID:
31400251
10.

Reliable, fast antidepressant treatment: restating the case for electroconvulsive therapy.

Sienaert P, Kellner CH.

Acta Psychiatr Scand. 2019 Sep;140(3):187-188. doi: 10.1111/acps.13071. No abstract available.

PMID:
31400004
11.

Inflammation and remission in older patients with depression treated with electroconvulsive therapy; findings from the MODECT study.

Carlier A, Berkhof JG, Rozing M, Bouckaert F, Sienaert P, Eikelenboom P, Veerhuis R, Vandenbulcke M, Berkhof J, Stek ML, Rhebergen D, Dols A, Exel EV.

J Affect Disord. 2019 Sep 1;256:509-516. doi: 10.1016/j.jad.2019.06.040. Epub 2019 Jul 1.

PMID:
31279250
12.

Brain-derived neurotrophic factor as a possible predictor of electroconvulsive therapy outcome.

van Zutphen EM, Rhebergen D, van Exel E, Oudega ML, Bouckaert F, Sienaert P, Vandenbulcke M, Stek M, Dols A.

Transl Psychiatry. 2019 May 24;9(1):155. doi: 10.1038/s41398-019-0491-9.

13.

MMSE Changes During and After ECT in Late-Life Depression: A Prospective Study.

Obbels J, Vansteelandt K, Verwijk E, Dols A, Bouckaert F, Oudega ML, Vandenbulcke M, Stek M, Sienaert P.

Am J Geriatr Psychiatry. 2019 Sep;27(9):934-944. doi: 10.1016/j.jagp.2019.04.006. Epub 2019 Apr 23.

PMID:
31104967
14.

The FDA Final Order on ECT Devices, Finally.

Kellner CH, McCall WV, Spaans HP, Sienaert P.

J ECT. 2019 Jun;35(2):69-70. doi: 10.1097/YCT.0000000000000601. No abstract available.

PMID:
31022040
15.

Electroconvulsive therapy response in late-life depression unaffected by age-related brain changes.

Bouckaert F, Emsell L, Vansteelandt K, De Winter FL, Van den Stock J, Obbels J, Dols A, Stek M, Adamczuk K, Sunaert S, Van Laere K, Sienaert P, Vandenbulcke M.

J Affect Disord. 2019 May 15;251:114-120. doi: 10.1016/j.jad.2019.03.055. Epub 2019 Mar 20.

PMID:
30921594
16.

Melancholia as Predictor of Electroconvulsive Therapy Outcome in Later Life.

Veltman EM, de Boer A, Dols A, van Exel E, Stek ML, Sienaert P, Bouckaert F, van der Mast R, Rhebergen D.

J ECT. 2019 Mar 5. doi: 10.1097/YCT.0000000000000579. [Epub ahead of print]

PMID:
30844880
17.

Temporal glioblastoma presenting as catatonia.

Franssen A, Sienaert P.

BMJ Case Rep. 2019 Mar 4;12(3). pii: e224017. doi: 10.1136/bcr-2017-224017.

PMID:
30837231
18.

The dynamical signature of anhedonia in major depressive disorder: positive emotion dynamics, reactivity, and recovery.

Heininga VE, Dejonckheere E, Houben M, Obbels J, Sienaert P, Leroy B, van Roy J, Kuppens P.

BMC Psychiatry. 2019 Feb 8;19(1):59. doi: 10.1186/s12888-018-1983-5.

19.

Exploring resting state connectivity in patients with psychotic depression.

Oudega ML, van der Werf YD, Dols A, Wattjes MP, Barkhof F, Bouckaert F, Vandenbulcke M, De Winter FL, Sienaert P, Eikelenboom P, Stek ML, van den Heuvel OA, Emsell L, Rhebergen D, van Exel E.

PLoS One. 2019 Jan 17;14(1):e0209908. doi: 10.1371/journal.pone.0209908. eCollection 2019.

20.

[Persistant underuse of ECT for persistant depressive disorder?]

Sienaert P.

Tijdschr Psychiatr. 2019;61(1):14-15. Dutch.

Supplemental Content

Loading ...
Support Center